Ticker
ENTACompany Name
ENANTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -0.1% | $ 162.04M | $ 162K |
3/31/2025 | -0.17% | $ 110.73M | $ 190K |
12/31/2024 | -0.19% | $ 125.01M | $ 241K |
9/30/2024 | -0.08% | $ 187.15M | $ 147K |
6/30/2024 | -0.03% | $ 262.1M | $ 79K |
3/31/2024 | -0.09% | $ 270.25M | $ 251K |
12/31/2023 | -0.41% | $ 261.49M | $ 1.08M |
9/30/2023 | -1.17% | $ 189.32M | $ 2.21M |
6/30/2023 | -1.32% | $ 389.95M | $ 5.14M |
3/31/2023 | -1.69% | $ 537.33M | $ 9.06M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for ENANTA PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 10.48M ]) / Market Cap [ $ 862.19M ]
(=) Buyback Yield [ -1.22% ]
Minimum
Sep 30, 2022
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.7% |